Researchers constantly seek innovative approaches to tackle cancer. One concept gaining traction is antifragility, a property where systems not only withstand stress but improve because of it.
FDA delays Moderna RSV vaccine decision, but what’s next is likely to be a tougher, longer climb
The FDA has delayed the PDUFA date for Moderna’s RSV vaccine, the company announced Friday morning. The delay likely won’t push the decision past the